Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for minimal hepatic encephalopathy in cirrhosis
2013-000563-81Phase 4Active
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of metformin in hepatic encephalopathy (HE) and Cirrhosis, sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Minimal hepatic encephalopathy improvement after reducing insulin resistance in patients treated with metformin. Started Jun 2013; status: active.
02
Drugs
metformin
03
Conditions
hepatic encephalopathy (HE)Cirrhosis
Beyond the preview
Go deeper on 2013-000563-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000563-81.